Frontiers in Pediatrics (May 2022)

Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review

  • Rong Yang,
  • Rong Yang,
  • Yuan Ai,
  • Yuan Ai,
  • Chuan Liu,
  • Chuan Liu,
  • Xiaoxi Lu,
  • Xiaoxi Lu

DOI
https://doi.org/10.3389/fped.2022.829927
Journal volume & issue
Vol. 10

Abstract

Read online

Aggressive natural killer cell leukemia (ANKL) is a rare malignant tumor, especially uncommon in children. ANKL has very aggressive clinical course and bad prognosis and is usually caused by Epstein-Barr virus infection. ANKL often has clinical manifestations of hemophagocytic lymphohistiocytosis (HLH) and can be easily treated as HLH, which might complicate this aggressive disease. Here we report an ANKL in adolescent whose clinical presentation was highly aggressive and response to L-asparaginase containing chemotherapy was very bad. Early-onset Flow cytometry of peripheral blood and bone marrow help make the diagnosis.

Keywords